{
      "brief_title": [
            "denosumab",
            "amg",
            "162",
            "bisphosphonate",
            "naive",
            "metastatic",
            "breast",
            "cancer"
      ],
      "brief_summary": [
            "study",
            "evaluate",
            "various",
            "dose",
            "schedule",
            "denosumab",
            "administration",
            "characterize",
            "safety",
            "profile",
            "indication"
      ],
      "condition": [
            "bone",
            "metastasis",
            "subject",
            "advance",
            "breast",
            "cancer"
      ],
      "intervention_type": [
            "drug"
      ],
      "intervention_name": [
            "iv",
            "bisphosphonates"
      ],
      "description": [
            "commercially",
            "available",
            "intravenous",
            "iv",
            "bisphosphonates",
            "administer",
            "per",
            "package",
            "insert",
            "include",
            "pamidronate",
            "ibandronic",
            "acid",
            "zoledronic",
            "acid"
      ],
      "arm_group_label": [
            "iv",
            "bisphosphonates",
            "every",
            "4",
            "week"
      ],
      "other_name": [
            "amg",
            "162"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "histologically",
            "cytologically",
            "confirm",
            "breast",
            "adenocarcinoma",
            "least",
            "one",
            "bone",
            "metastasis"
      ],
      "gender": [
            "female"
      ],
      "minimum_age": [
            "18",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": false,
      "id": "NCT00091832.xml"
}